Osaic Holdings’s ImmuCell ICCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.93K Hold
391
﹤0.01% 7039
2026
Q1
$2.48K Hold
391
﹤0.01% 6972
2025
Q4
$2.4K Hold
391
﹤0.01% 7024
2025
Q3
$2.42K Hold
391
﹤0.01% 7082
2025
Q2
$2.72K Hold
391
﹤0.01% 6827
2025
Q1
$1.87K Hold
391
﹤0.01% 6622
2024
Q4
$2.01K Buy
+391
New +$1.56K ﹤0.01% 6605
2024
Q1
Sell
-550
Closed -$2.8K 7290
2023
Q4
$2.8K Buy
+550
New +$2.68K ﹤0.01% 6403
2023
Q3
Sell
-550
Closed -$2.75K 7451
2023
Q2
$2.75K Buy
+550
New +$2.81K ﹤0.01% 6553

Other funds holding ICCC

Osaic Holdings's ICCC Position: Q2 2026 in Review

Osaic Holdings held its ImmuCell (ICCC) position steady in Q2 2026 at 391 shares worth $3.93K. The position accounts for ﹤0.01% of the portfolio, ranked #7039.

Osaic Holdings first reported a position in ICCC in Q2 2023 and has held it in 9 quarters since. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

  • Osaic Holdings held 391 shares of ImmuCell worth $3.93K as of Q2 2026.
  • Osaic Holdings left its ImmuCell share count unchanged in Q2 2026.
  • ImmuCell made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7039 holding.
  • Osaic Holdings first reported a position in ImmuCell in Q2 2023 and has held it in 9 quarters since.
  • 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.